Effects of Cisapride on QTc Interval and QT Dispersion in Preterm Infants

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Korean Journal of Pediatrics

• Publication date

  2000-02-15

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisapride

  2012cited by this paper
• Long QT syndrome

  2010cited by this paper
• Cisapride: a survey of the frequency of use and adverse events in premature newborns.

  1999cited by this paper
• Effects of Cisapride on QT Interval in Children † 119

  1998cited by this paper
• Prolongation of the QT interval and the sudden infant death syndrome.

  1998cited by this paper
• The Science and Practice of Pediatric Cardiology

  1998cited by this paper
• Effects of cisapride on QTc interval in term neonates

  1997cited by this paper
• Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?

  1997cited by this paper
• Cisapride and fatal arrhythmia.

  1996cited by this paper
• Cisapride-induced long QT interval.

  1996cited by this paper
• Cisapride‐induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres

  1996cited by this paper
• Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de Pointes

  1995cited by this paper
• Long QT syndrome during high-dose cisapride.

  1995cited by this paper
• Cisapride and torsades de pointes

  1995cited by this paper
• QT dispersion and sudden unexpected death in chronic heart failure.

  1994cited by this paper
• Cisapride: A Gastrointestinal Prokinetic Drug

  1994cited by this paper
• The role of cytochrome P450 in developmental pharmacology.

  1994cited by this paper
• Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.

  1993cited by this paper
• Tachycardia during cisapride treatment.

  1992cited by this paper
• Precordial QT Interval Dispersion as a Marker of Torsade de Pointes: Disparate Effects of Class Ta Antiarrhythmic Drugs and Amiodarone

  1992cited by this paper
• Reduction in QT dispersion by sotalol following myocardial infarction.

  1991cited by this paper
• QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.

  1990cited by this paper
• Importance of lead selection in QT interval measurement.

  1988cited by this paper
• The Sudden Infant Death Syndrome: Cardiac and Respiratory Mechanisms and Interventions

  1988cited by this paper
• Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease.

  1986cited by this paper
• Apnea associated with regurgitation in infants.

  1985cited by this paper
• Awake apnea associated with gastroesophageal reflux: a specific clinical syndrome.

  1984cited by this paper
• The QT Interval Throughout the First 6 Months of Life: A Prospective Study

  1982cited by this paper
• The Q‐T Interval in Normal Infants and Children

  1950cited by this paper

• No citing papers are available for this paper.